Commitment to Building Out Healthcare Technology Franchise

Oppenheimer & Co. Inc. announced that Rishi Soni has joined the firm as an Executive Director focused on Healthcare Technology (HealthTech). He will be based out of Oppenheimer’s New York headquarters and report to Robin Graham, Head of Technology Investment Banking, while partnering closely with Oppenheimer’s Healthcare Investment Banking team.

Robin Graham comments, “Rishi underscores Oppenheimer’s ongoing commitment to building out a team of senior investment bankers with deep sector expertise in key growth verticals of the global economy. Healthcare represents over 18% of national GDP¹ with technology acting as a key lever to revolutionize and bring much needed efficiencies to this massive industry over the long-term. Rishi’s deep expertise in the sector, along with his experience working across M&A and capital markets transactions for high growth businesses in HealthTech is highly differentiated.”

Rishi joins Oppenheimer with more than nine years of experience in the Healthcare Services and Healthcare Technology sectors. Prior to joining Oppenheimer, he was a senior banker in the Healthcare practices at Deutsche Bank and UBS Investment Bank, where he worked on over $10B of closed M&A and financing transactions. Rishi’s experience spans the growth spectrum, ranging from high growth startups to unicorns and some of the most prominent public companies in the Healthcare sector.

“I am delighted to join the team at Oppenheimer. It is an honor to partner with a team of accomplished professionals across both Technology and Healthcare” says Rishi. “Oppenheimer’s commitment to working with companies at key inflection points on their growth trajectory resonates with me and I look forward to continue working to build out the franchise.”

Marc Cabrera, Co-Head of Healthcare Investment Banking adds, “There’s an undeniable invasion of big tech into legacy healthcare services and we’re seeing this across nearly every traditional healthcare model. As such, we’re thrilled to have Rishi join our coverage effort given how important it is for our industry to have the HealthTech perspective inform our clients’ views on M&A and financing.”